2015
DOI: 10.5505/tjoncol.2015.1164
|View full text |Cite
|
Sign up to set email alerts
|

Elevated alpha-fetoprotein in benign/borderline liver masses in children

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 6 publications
(13 reference statements)
0
2
0
Order By: Relevance
“…Another case of 11-monthold boy presenting with mesenchymal hamartoma had AFP levels of 3829 ng/mL. Dogan Kose et al [4] reported in the retrospective study done on 5 patients between 2006 and 2012 who were diagnosed with benign/ borderline liver masses that elevated AFP levels can be seen in benign liver masses and they can wrongly suggest malignant liver tumours. AFP levels were between 123 ng/mL and 4905 ng/mL in patients with median age of 6 months among whom 2 were diagnosed with haemangioendothelioma, 1 had mesenchymal hamartoma, 1 had haemangioma and 1 had focal nodular hyperplasia.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Another case of 11-monthold boy presenting with mesenchymal hamartoma had AFP levels of 3829 ng/mL. Dogan Kose et al [4] reported in the retrospective study done on 5 patients between 2006 and 2012 who were diagnosed with benign/ borderline liver masses that elevated AFP levels can be seen in benign liver masses and they can wrongly suggest malignant liver tumours. AFP levels were between 123 ng/mL and 4905 ng/mL in patients with median age of 6 months among whom 2 were diagnosed with haemangioendothelioma, 1 had mesenchymal hamartoma, 1 had haemangioma and 1 had focal nodular hyperplasia.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, AFP levels are also used as a marker for response to treatment, prognosis and to determine the outcome of malignant liver tumours. [3] However, Dogan et al [4] reported that benign liver conditions like haemangioendotheliomas, mesenchymal hamartomas, cases of hepatic insult and regeneration like hepatitis and cirrhosis also show increased AFP levels. AFP monitoring is vital in management of hepatic tumours.…”
mentioning
confidence: 99%